Skip to main content
. 2023 Oct 11;5:100189. doi: 10.1016/j.cccb.2023.100189

Panel 1 - Neuropathologist's viewpoint of in vivo models

Be clear about what the model is actually modelling. What aspect of the human spectrum of SVD is being assessed?
Where possible, compare or relate animal model tissue-level observations to human tissues. Is the animal model observation relevant to the human disease?
SVD – even quite severe SVD – can be clinically silent
A “good” model need not have cognitive phenotypes
A SVD model needs some vascular pathology